Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GPC Biotech To Cut 38 Percent Of Workforce

Feb 26 2008

• By Jessica Merrill

Related Content

GPC Biotech’s Satraplatin Fails To Meet Survival Endpoint In SPARC Trial

Oct 31 2007

GPC Biotech Plans Restructuring To Cut Costs Following SPARC Failure

Nov 08 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window